The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma

References

• Guo Z, Jiang P, Dong Q, et al. RNF149 Promotes HCC Progression through Its E3 Ubiquitin Ligase Activity. Cancers. 2023;15(21):5203. doi:10.3390/cancers15215203
   PubMed Web of Science ®Google Scholar
• Hafezi M, Lin M, Chia A, et al. Immunosuppressive Drug-Resistant Armored T-Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients. Hepatology. 2021;74(1):200–213. doi:10.1002/hep.31662
   PubMed Web of Science ®Google Scholar
• Zheng B, Liu XL, Fan R, et al. The landscape of cell-free hbv integrations and mutations in cirrhosis and hepatocellular carcinoma patients. Clin Cancer Res. 2021;27(13):3772–3783. doi:10.1158/1078-0432.CCR-21-0002
   PubMed Web of Science ®Google Scholar
• Singh A, Zahid S, Noginskiy I, et al. A review of current and emerging therapies for advanced hepatocellular carcinoma. Curr Oncol. 2022;29(9):6445–6462. doi:10.3390/curroncol29090507
   PubMed Web of Science ®Google Scholar
• You M, Gao Y, Fu J, et al. Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC. Hepatology. 2023;78(3):943–958. doi:10.1097/HEP.0000000000000369
   PubMed Web of Science ®Google Scholar
• Yang Y, Hou N, Wang X, et al. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A. Oncotarget. 2015;6(18):16227–16238. doi:10.18632/oncotarget.3970
   PubMed Web of Science ®Google Scholar
• Galle PR, Foerster F, Kudo M, et al. Biology and significance of alpha-fetoprotein in hepatocellular carcinoma. Liver Int. 2019;39(12):2214–2229. doi:10.1111/liv.14223
   PubMed Web of Science ®Google Scholar
• Necula L, Matei L, Dragu D, et al. Collagen family as promising biomarkers and therapeutic targets in cancer. Int J Mol Sci. 2022;23(20):12415. doi:10.3390/ijms232012415
   PubMed Web of Science ®Google Scholar
• Huang X, Wang H, Xu F, et al. Overexpression of chaperonin containing TCP1 subunit 7 has diagnostic and prognostic value for hepatocellular carcinoma. Aging. 2022;14(2):747–769. doi:10.18632/aging.203809
   PubMedGoogle Scholar
• Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154(1):26–46. doi:10.1016/j.cell.2013.06.020
   PubMed Web of Science ®Google Scholar
• Zhao Y, Teng H, Yao F, Yap S, Sun Y, Ma L. Challenges and Strategies in ascribing functions to long noncoding RNAs. Cancers. 2020;12(6):1458. doi:10.3390/cancers12061458
   PubMed Web of Science ®Google Scholar
• Qu J, Tao D, Huang W, et al. Assessment of prognostic role of a novel 7-lncRNA signature in HCC patients. Heliyon. 2023;9(8):e18493. doi:10.1016/j.heliyon.2023.e18493
   PubMed Web of Science ®Google Scholar
• Gan B, He Y, Ma Y, et al. Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma. Front Pharmacol. 2023;8(14):1167418. doi:10.3389/fphar.2023.1167418
   Google Scholar
• Motawi TK, Mady AE, Elhelbawy M, et al. Association of long noncoding RNA H19 rs2839698 C/T with hepatitis B virus infection and hepatocellular carcinoma risk. J Biochem Mol Toxic. 2024;38(4):e23673. doi:10.1002/jbt.23673
   PubMed Web of Science ®Google Scholar
• Fu Y, Si A, Wei X, et al. Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma. BMC Genomics. 2023;24(1):89. doi:10.1186/s12864-023-09194-8
   PubMed Web of Science ®Google Scholar
• Zhao D, Zhang X, Tang Y, et al. Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology. J Hepatocell Carcinoma. 2022;9:389–403. doi:10.2147/JHC.S357380
   PubMed Web of Science ®Google Scholar
• Lampertico P, Agarwal K, Berg T, European Association for the Study of the Liver. Electronic address eee, European Association for the study of the L. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370–398. doi:10.1016/j.jhep.2017.03.021
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460. doi:10.1016/j.jhep.2018.03.024
   PubMed Web of Science ®Google Scholar
• Vogel A, Cervantes A, Chau I, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv238–iv255. doi:10.1093/annonc/mdy308
   PubMed Web of Science ®Google Scholar
• Zhu S, Huang X, Zhang K, et al. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. Cancer Med. 2019;8(18):7679–7692. doi:10.1002/cam4.2618
   PubMed Web of Science ®Google Scholar
• Ferenci P, Fried M, Labrecque D, et al. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol. 2010;44(4):239–245. doi:10.1097/MCG.0b013e3181d46ef2
   PubMed Web of Science ®Google Scholar
• Erstad DJ, Tanabe KK. Hepatocellular carcinoma: early-stage management challenges. J Hepatocell Carcinoma. 2017;4:81–92. doi:10.2147/JHC.S107370
   PubMed Web of Science ®Google Scholar
• Wang Y, Pei L, Yue Z, Jia M, Wang H, Cao LL. The Potential of Serum Exosomal hsa_circ_0028861 as the Novel Diagnostic Biomarker of HBV-Derived Hepatocellular Cancer. Front Genet. 2021;12:703205. doi:10.3389/fgene.2021.703205
   PubMed Web of Science ®Google Scholar
• Hanif H, Ali MJ, Susheela AT, et al. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol. 2022;28(2):216–229. doi:10.3748/wjg.v28.i2.216
   PubMed Web of Science ®Google Scholar
• Xu G, Meng L, Yuan D, et al. MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer. Oncol Rep. 2018;40(1):39–48. doi:10.3892/or.2018.6424
   PubMed Web of Science ®Google Scholar
• Wang Z, Gao P, Sun W, et al. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma. Front Endocrinol. 2023;14:938102. doi:10.3389/fendo.2023.938102
   PubMed Web of Science ®Google Scholar
• Mo C, Wu J, Sui J, et al. Long non-coding RNA LINC01793 as a potential diagnostic biomarker of hepatitis B virus-related hepatocellular carcinoma. Clin Biochem. 2022;108:56–62. doi:10.1016/j.clinbiochem.2022.06.006
   PubMed Web of Science ®Google Scholar
• Wang K, Guo WX, Li N, et al. Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma. PLoS One. 2015;10(12).
   Web of Science ®Google Scholar
• Han Z, Feng W, Hu R, et al. RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma. Sci Rep. 2021;11(1):17797. doi:10.1038/s41598-021-96952-x
   PubMed Web of Science ®Google Scholar
• Kunadirek P, Pinjaroen N, Nookaew I, Tangkijvanich P, Chuaypen N. Transcriptomic analyses reveal long non-coding RNA in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. Int J Mol Sci. 2022;23(14):7882. doi:10.3390/ijms23147882
   PubMed Web of Science ®Google Scholar
• Hu R, Zhang W, Han Z, et al. Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma. BMC Gastroenterol. 2023;23(1):234. doi:10.1186/s12876-023-02843-y
   PubMed Web of Science ®Google Scholar
• Di Martino MT, Riillo C, Scionti F, et al. miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy. Cancers. 2021;13(7):1587. doi:10.3390/cancers13071587
   PubMed Web of Science ®Google Scholar
• Wu D, Sun J, Wang H, Ma C. LncRNA SOCS2-AS1 promotes the progression of glioma via regulating ITGB1 expression. Neurosci Lett. 2021;765:136248. doi:10.1016/j.neulet.2021.136248
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang X, Yang G, et al. LncRNA SOCS2-AS1 promotes the progression of papillary thyroid cancer by destabilizing p53 protein. Biochem Biophys Res Commun. 2023;669:95–102. doi:10.1016/j.bbrc.2023.05.080
   PubMed Web of Science ®Google Scholar
• Misawa A, Takayama K, Urano T, Inoue S. Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells. J Biol Chem. 2016;291(34):17861–17880. doi:10.1074/jbc.M116.718536
   PubMed Web of Science ®Google Scholar
• Zhong F, Wang Y. YY1-regulated lncRNA SOCS2-AS1 suppresses HCC cell stemness and progression via miR-454-3p/CPEB1. Biochem Biophys Res Commun. 2023;679:98–109. doi:10.1016/j.bbrc.2023.08.056
   PubMed Web of Science ®Google Scholar
• Fu P, Gong B, Li H, et al. Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus-related hepatocellular carcinoma. Int, J, Cancer. 2022;151(10):1824–1834. doi:10.1002/ijc.34201
   PubMed Web of Science ®Google Scholar